ALISSA MCGEE: Open Payments
NPI 1790168284 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,415 in 64 payments from 27 companies in 2025. Trend: 2023 $403 · 2024 $1,383 · 2025 $1,415
Food & beverage: $1,402Education: $13
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $209 |
| AstraZeneca Pharmaceuticals LP | 6 | $167 |
| Incyte Corporation | 5 | $113 |
| PFIZER INC. | 6 | $111 |
| Novartis Pharmaceuticals Corporation | 3 | $86 |
| ARRAY BIOPHARMA INC | 10 | $86 |
| Genentech USA, Inc. | 3 | $74 |
| BeOne Medicines USA, Inc. | 2 | $48 |
| Gilead Sciences, Inc. | 2 | $45 |
| Daiichi Sankyo Inc. | 2 | $45 |
Products named: LYNPARZA, ERLEADA, JAKAFI, IBRANCE, BRAFTOVI, RYBREVANT, BRUKINSA, Tecentriq.
Industry payments across GA — which companies pay providers there.
